Stem cell transplant and Ejection fraction decreased

Summary:

Ejection fraction decreased is found among people with Stem cell transplant, especially for people who are 20-29 old.

The study analyzes which people have Ejection fraction decreased with Stem cell transplant. It is created by eHealthMe based on reports of 16 people who have Stem cell transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Stem cell transplant?

Stem cell transplant is found to be associated with 431 drugs and 383 conditions by eHealthMe. Check the latest studies of Stem cell transplant.

What is Ejection fraction decreased?

Ejection fraction decreased (systolic heart failure) is found to be associated with 1,065 drugs and 1,252 conditions by eHealthMe. Check the latest studies of Ejection fraction decreased.



On Jul, 14, 2026

16 people who have Stem Cell Transplant and Ejection Fraction Decreased are studied.

Would you have Ejection fraction decreased when you have Stem cell transplant?

Age of people who have Stem Cell Transplant and experienced Ejection Fraction Decreased *:

  • 0-1: 0.0 %
  • 2-9: 13.33 %
  • 10-19: 0.0 %
  • 20-29: 46.67 %
  • 30-39: 0.0 %
  • 40-49: 6.67 %
  • 50-59: 20.0 %
  • 60+: 13.33 %

Common co-existing conditions for these people *:

  1. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 31.25%
  2. B Precursor Type Acute Leukaemia (lymphoid cancer): 5 people, 31.25%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 31.25%
  4. Bone Marrow Conditioning Regimen: 3 people, 18.75%
  5. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 12.50%

Common drugs taken by these people *:

  1. Heparin: 5 people, 31.25%
  2. Cyclosporine: 4 people, 25.00%
  3. Cytarabine: 3 people, 18.75%
  4. Fludara: 3 people, 18.75%
  5. Methotrexate: 3 people, 18.75%
  6. Busulfan: 2 people, 12.50%
  7. Campath: 2 people, 12.50%
  8. Ciclosporin: 2 people, 12.50%
  9. Cyclophosphamide: 2 people, 12.50%
  10. Vincristine Sulfate: 1 person, 6.25%

Common symptoms for these people *:

  1. Left Ventricular Dysfunction: 7 people, 43.75%
  2. Pleural Effusion (water on the lungs): 6 people, 37.50%
  3. Carotid Intima-Media Thickness Increased (increased thickness of carotid artery muscle): 5 people, 31.25%
  4. Cardiotoxicity (damage to the heart muscle): 5 people, 31.25%
  5. Adenovirus Infection: 5 people, 31.25%
  6. Ankle Brachial Index Decreased: 5 people, 31.25%
  7. Pulse Waveform Abnormal: 5 people, 31.25%
  8. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 4 people, 25.00%
  9. Pericardial Effusion (fluid around the heart): 4 people, 25.00%
  10. Cardiac Failure: 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ejection fraction decreased?

- Check whether Ejection fraction decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Ejection fraction decreased:

All the conditions that are associated with Ejection fraction decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ejection fraction decreased and Stem cell transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: